Instagram
youtube
Facebook

Director, Global Drug Safety & Pharmacovigilance Physician

12+ years
$170,625.00---$284,375.00
12 May 17, 2024
Job Description
Job Type: Full Time Education: MD Skills: Causality Assessment, Communication Skills, ICD-10 CM, CPT, HCPCS Coding, ICSR Case Processing, Interpersonal Skill, Labelling Assessment, MedDRA Coding, Narrative Writing, Research & Development, Technical Skill, Triage of ICSRs, WHO DD Coding

Job Title: Director, GDS&PV Physician

Company: Genmab

Location: Flexible; includes Copenhagen, Denmark; Utrecht, the Netherlands; Princeton, New Jersey, USA; and Tokyo, Japan.

Employment Type: Full-time

Salary Range: $170,625.00 - $284,375.00 (For US-based candidates)

About the Company: Genmab is an international biotechnology company dedicated to improving the lives of patients through innovative antibody therapeutics. With a robust pipeline and strategic partnerships, Genmab is focused on pioneering cancer treatments and addressing serious diseases. Established in 1999, Genmab has offices in Copenhagen, Utrecht, Princeton, and Tokyo.

Job Summary: The Director, GDS&PV Physician will lead major safety-related activities and ensure the global safety strategy for Genmab products, primarily investigational. This role involves cross-functional collaboration, regulatory compliance, and mentoring junior colleagues.

Key Responsibilities:

  • Lead pre- and post-marketing safety activities, including signal and risk management.
  • Collaborate with cross-functional teams for safety assessment and communication.
  • Oversee safety issue handling and risk mitigation.
  • Provide inputs for trial protocols, clinical trial reports, and related documents.
  • Prepare regulatory documentation, including safety summaries.
  • Manage forums like Data Monitoring Committees and Safety Committees.
  • Train and mentor team members on safety and PV processes.
  • Engage with internal and external stakeholders regarding safety and regulatory issues.
  • Support the Clinical Research Department with case processing.
  • Participate in training and inspections related to PV processes.

Qualifications:

  • MD required.
  • Minimum 12+ years in drug safety/pharmacovigilance, preferably in oncology.
  • Experience with PV audits and regulatory authority inspections.
  • Knowledge of global PV regulations, MedDRA, WHODrug coding, and safety databases (ARISg, ARGUS).
  • Proven leadership and mentoring skills.
  • Strong analytical and communication skills.

Skills:

  • Proficient in safety databases and electronic data capture systems.
  • Ability to manage multiple projects and deadlines.
  • Excellent written and verbal communication.
  • Strong team collaboration and mentoring capabilities.

Work Environment: Genmab offers an agile working environment with a balance of remote and in-office work. The offices are designed as open, community-based spaces to foster collaboration and innovation.

Diversity Commitment: Genmab is committed to diversity, equity, and inclusion. All applicants will be considered without regard to race, color, religion, sex, national origin, age, disability, or genetic information.

Application Process: Please visit Genmab Careers to apply and review our privacy policy for handling your data.

Additional Information:

  • For positions in the Netherlands, initial employment contracts are fixed-term for one year, with potential renewal for an indefinite term based on performance and business conditions.
  • Benefits include medical, dental, vision, and 401k.

About You:

  • Passionate about transforming patient lives through innovative treatments.
  • Rigorous and excellence-driven in problem-solving.
  • Collaborative team player with diverse backgrounds.
  • Determined to achieve and enable the best work.
  • Innovative and adaptable in a dynamic company.
  • Enjoys working hard and having fun.

Join Genmab: If you are ready to be part of a groundbreaking team at the intersection of healthcare and technology, apply now and help us revolutionize cancer treatment and serious disease therapies.